BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang T, Xu R, Huo J, Wang B, Du X, Dai B, Zhu M, Zhan Y, Zhang D, Zhang Y. WWOX activation by toosendanin suppresses hepatocellular carcinoma metastasis through JAK2/Stat3 and Wnt/β-catenin signaling. Cancer Lett 2021;513:50-62. [PMID: 34015398 DOI: 10.1016/j.canlet.2021.05.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Yang Y, Zhou C, Mei X, Liu J, Luo K, Zhou J, Qin C, Zeng Z. WWOX activates autophagy to alleviate lipopolysaccharide-induced acute lung injury by regulating mTOR. Int Immunopharmacol 2023;115:109671. [PMID: 36621327 DOI: 10.1016/j.intimp.2022.109671] [Reference Citation Analysis]
2 Wang G, Li L, Li Y, Zhang LH. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway. Phytomedicine 2023;109:154571. [PMID: 36610147 DOI: 10.1016/j.phymed.2022.154571] [Reference Citation Analysis]
3 Luo L, Liang Y, Fu Y, Liang Z, Zheng J, Lan J, Shen F, Huang Z. Toosendanin Induces Hepatocyte Damage by Inhibiting Autophagic Flux via TFEB-Mediated Lysosomal Dysfunction. Pharmaceuticals (Basel) 2022;15. [PMID: 36558960 DOI: 10.3390/ph15121509] [Reference Citation Analysis]
4 Chu Y, Liu H, Chen Y, Chou C, Yeh C. WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.996820] [Reference Citation Analysis]
5 Yang T, Cheng C, Xu R, Huo J, Peng X, Chen Y, Liang Y, Su Z, Zhang Y. Albendazole exerts an anti-hepatocellular carcinoma effect through a WWOX-dependent pathway. Life Sciences 2022;310:121086. [DOI: 10.1016/j.lfs.2022.121086] [Reference Citation Analysis]
6 He X, Wang N, Zhang Y, Huang X, Wang Y. The therapeutic potential of natural products for treating pancreatic cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1051952] [Reference Citation Analysis]
7 Zou M, Fan R, Yin A, Hu R, Huang D, Li W, Yin S, Pu R, Tang G. Discovery of 29-O-acyl-toosendanin-based derivatives as potent anti-cancer agents. Arabian Journal of Chemistry 2022;15:104283. [DOI: 10.1016/j.arabjc.2022.104283] [Reference Citation Analysis]
8 Yao H, Ren D, Wang Y, Wu L, Wu Y, Wang W, Li Q, Liu L. KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. Cell Death Dis 2022;13:761. [PMID: 36055981 DOI: 10.1038/s41419-022-05200-1] [Reference Citation Analysis]
9 Zhang M, Lu C, Su L, Long F, Yang X, Guo X, Song G, An T, Chen W, Chen J. Toosendanin activates caspase-1 and induces maturation of IL-1β to inhibit type 2 porcine reproductive and respiratory syndrome virus replication via an IFI16-dependent pathway. Vet Res 2022;53:61. [PMID: 35906635 DOI: 10.1186/s13567-022-01077-2] [Reference Citation Analysis]
10 Liu T, Nagarajan G, Chiang M, Huang S, Lin T, Chen Y, Sze C, Chang N. WWOX Controls Cell Survival, Immune Response and Disease Progression by pY33 to pS14 Transition to Alternate Signaling Partners. Cells 2022;11:2137. [DOI: 10.3390/cells11142137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Guo D, Zhang X, Cui H, Yu D, Zhang H, Shi X, Pang C, Li J, Guo W, Zhang S. ACADL Functions as a Tumor Suppressor in Hepatocellular Carcinoma Metastasis by Inhibiting Matrix Metalloproteinase 14. Front Oncol 2022;12:821484. [DOI: 10.3389/fonc.2022.821484] [Reference Citation Analysis]